EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity

Tim Hropot iD, Rok Herman iD, Andrej Janez iD, Luka Lezaic, Mojca Jensterle iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24108592 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tim Hropot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Adipose Tissue, Brown, Cardiovascular Diseases, Obesity, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipose tissue can be divided into white adipose tissue (WAT), brown adipose tissue (BAT), and beige adipose tissue, according to the differences in morphology. WAT acts as a buffer for increased energy intake and decreased energy expenditure during the development of obesity, resulting in visceral and ectopic WAT accumulation. These WAT depots are strongly associated with chronic systemic inflammation, insulin resistance, and cardiometabolic risk related to obesity. They represent a primary weight loss target in anti-obesity management. Second-generation anti-obesity medications glucagon-like peptide-1 receptor agonists (GLP-1RAs) cause weight loss and improve body composition by reducing visceral and ectopic fat depots of WAT, resulting in improved cardiometabolic health. Recently, the understanding of the physiological significance of BAT beyond its primary function in generating heat through non-shivering thermogenesis has been expanded. This has raised scientific and pharmaceutical interest in the manipulation of BAT to further enhance weight reduction and body weight maintenance. This narrative review focuses on the potential impact of GLP-1 receptor agonism on BAT, particularly in human clinical studies. It provides an overview of the role of BAT in weight management and highlights the need for further research to elucidate the mechanisms by which GLP-1RAs affect energy metabolism and weight loss. Despite encouraging preclinical data, limited clinical evidence supports the notion that GLP-1RAs contribute to BAT activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose Tissue, BrownCardiovascular DiseasesObesityGlucagon-Like Peptide-1 Receptor AgonistsHumansAdipose Tissue, WhiteEnergy MetabolismGlucagon-Like Peptide 1ThermogenesisWeight LossAnimals

Stichwörter der Autor:innen

brown adipose tissueenergy expenditureglucagon-like peptide-1 receptor agonistsobesityweight loss

Substanzen

Glucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, 1000 Ljubljana, Slovenia.
  • Department for Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
  • Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • Department for Nuclear Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.

ORCID-Profile: Tim Hropot, Rok Herman, Andrej Janez, Mojca Jensterle

Förderung

  • Slovenian Research Agency

Zitieren

APA

Hropot, T., Herman, R., Janez, A., Lezaic, L., & Jensterle, M. (2023). Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108592

Vancouver

Hropot T, Herman R, Janez A, Lezaic L, Jensterle M. Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108592

BibTeX
@article{Hropot2023,
  author = {Hropot, Tim and Herman, Rok and Janez, Andrej and Lezaic, Luka and Jensterle, Mojca},
  title = {Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24108592}
}
Kostenlos starten →